Ducaling, Menda O.
HRN: 16-41-55 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/07/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/07/2024
06/14/2024
IVT
600 Mg
Q8h
Infected Wound
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes